Outcomes with first-versus second-generation drug-eluting stents in coronary chronic total occlusions (CTOs): A systematic review and meta-analysis

Journal of Invasive Cardiology

Volumn 26, Issue 7, 2014, Pages 304-310

  Lanka, Viswanatha ^a   Patel, Vishal G ^a   Saeed, Bilal ^b   Kotsia, Anna ^a   Christopoulos, George ^a   Rangan, Bavana V ^a   Mohammad, Atif ^a   Luna, Michael ^a   Garcia, Santiago ^c   Abdullah, Shuaib M ^a   Grodin, Jerrold ^a   Hastings, Jeffrey L ^a   Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

bare metal stent; everolimus eluting stent; paclitaxel eluting stent; percutaneous coronary intervention; restenosis; sirolimus eluting stent; zotarolimus eluting stent

Indexed keywords

BARE METAL STENT; CORONARY ARTERY OCCLUSION; DEATH; DEVICES; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; INCIDENCE; META ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; REVASCULARIZATION; REVIEW; STENT THROMBOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; AGED; CLASSIFICATION; COMPARATIVE STUDY; CORONARY OCCLUSION; FEMALE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CORONARY OCCLUSION; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; THROMBOSIS; TREATMENT OUTCOME;

EID: 84904009049     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Garcia S, Abdullah S, Banerjee S, Brilakis ES. Chronic total occlusions: patient selection and overview of advanced techniques. Curr Cardiol Rep. 2013;15(2):334.
2. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005;112(16): 2530-2537.
3. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation. 2005;112(15): 2364-2372.
4. Brilakis ES, Grantham JA, Thompson CA et al. The retrograde approach to coronary artery chronic total occlusions: a practical approach. Catheter Cardiovasc Interv. 2012;79(1):3-19. Epub 2011 Oct 5.
5. Brilakis ES, Grantham JA, Rinfret S et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5(4): 367-379.
6. Whitlow PL, Burke MN, Lombardi WL, et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial. JACC Cardiovasc Interv. 2012;5(4): 393-401.
7. Michael TT, Karmpaliotis D, Brilakis ES, et al. Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry) Am J Cardiol. 2013;112(4): 488-492.
8. Galassi AR, Tomasello SD, Reifart N, et al. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention. 2011;7(4): 472-479.
9. Morino Y, Kimura T, Hayashi Y, et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv. 2010;3(2): 143-151.
10. Colmenarez HJ, Escaned J, Fernandez C, et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(17): 1854-1866.
11. Saeed B, Kandzari DE, Agostoni P, et al. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2011;77(3): 315-32.
12. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med. 2013;368(3): 254-265.
13. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med. 2010;362(18): 1663-1674.
14. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010;375(9710): 201-209.
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
16. Moreno R, Garcia E, Teles R, et al. Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial. Circ Cardiovasc Interv. 2013;6(1): 21-28.
17. Park HJ, Kim HY, Lee JM, et al. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion - CAtholic Total Occlusion Study (CATOS) trial. Circ J. 2012;76(4):868-875. Epub 2012 Jan 25.
18. Suttorp MJ, Laarman GJ. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study. Am Heart J. 2007;154(3): 432-435.
19. Valenti R, Vergara R, Migliorini A, et al. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion. J Am Coll Cardiol. 2013;61(5):545-550. Epub 2012 Dec 26.
20. Almalla M, Hennings V, Marx N, Hoffmann R. Long-term clinical and angiographic outcome after treatment of chronic total occlusion with everolimus or sirolimus eluting stents. Int J Cardiol. 2012;157(3): 451-452.
21. Valenti R, Vergara R, Migliorini A, et al. Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions. Am J Cardiol. 2011;107(12): 1768-1771.
22. Park KW, Kang SH, Velders MA, et al. Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J. 2013;165(2): 241-250.
23. Wei G, Fang Y, Yaqi R, Lin C, Ningfu W. Clinical outcomes of zotarolimus-eluting stents versus the first generation sirolimus-eluting stents and paclitaxel-eluting stents: a meta-analysis of randomized trials. Int J Cardiol. 2012;157(1): 152-156.
24. Kandzari DE, Rao SV, Moses JW, et al. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. JACC Cardiovasc Interv. 2009;2(2): 97-106.
25. Van Dyck CJ, Hoymans VY, Haine S, Vrints CJ. New-generation drug-eluting stents: focus on Xience V(R) everolimus-eluting stent and Resolute(R) zotarolimus-eluting stent. J Interv Cardiol. 2013;26(3): 278-286.
26. Whitbeck MG, Applegate RJ. Second generation drug-eluting stents: a review of the everolimus-eluting platform. Clin Med Insights Cardiol. 2013;7: 115-126.
27. Papafaklis MI, Chatzizisis YS, Naka KK, Giannoglou GD, Michalis LK. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy. Pharmacol Ther. 2012;134(1): 43-53.
28. Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379(9824): 1393-1402.
29. Michael TT, Papayannis AC, Banerjee S, Brilakis ES. Subintimal dissection/reentry strategies in coronary chronic total occlusion interventions. Circ Cardiovasc Interv. 2012;5(5): 729-738.
30. Stojkovic S, Sianos G, Katoh O, et al. Efficiency, safety, and long-term follow-up of retrograde approach for CTO recanalization: initial (Belgrade) experience with international proctorship. J Interv Cardiol. 2012;25(6): 540-548.